Polycystic Ovary Syndrome
Conditions
Interventions
This is a randomized clinical trial with 2 arms, double blind and placebo controlled, the experimental group consisted of 14 women with polycystic ovary syndrome and overweight who received curcumin c
Sponsors
Centro de Saúde Escola da Faculdade de Medicina de Ribeirão Preto - USP
Centro de Saúde Escola da Faculdade de Medicina de Ribeirão Preto - USP
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: The sample consisted of women diagnosed with polycystic ovary syndrome who met the inclusion criteria which are women aged between 18 and 40 years; women classified as overweight and obesity grade I and II with body mass index greater than or equal to 25 kilograms per square meter and less than or equal to 39.9 kilograms per square meter
Exclusion criteria
Exclusion criteria: Participants were excluded from the study if they reported an allergy to curcumin or its derivatives, or presented with any of the following conditions pregnancy or breastfeeding period; late-onset congenital adrenal hyperplasia; androgen-secreting tumors; thyroid dysfunction; hyperprolactinemia; cushing's syndrome; ovarian insufficiency; hypothalamic amenorrhea; chronic kidney disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected to find a significant improvement in metabolic parameters and antioxidant capacity of overweight women with polycystic ovary syndrome after 12 weeks of curcumin supplementation, compared to the placebo group. | — |
Secondary
| Measure | Time frame |
|---|---|
| No secondary outcomes are expected. | — |
Countries
Brazil
Contacts
Public ContactJúlia Ramos
Faculdade de Medicina de Ribeirão Preto
Outcome results
None listed